Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.2 USD | -1.12% | -2.73% | -19.52% |
29/04 | Barclays Adjusts Price Target on Gilead Sciences to $76 From $80 | MT |
26/04 | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.52% | 82.23B | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Market Chatter: US Appeals Court Overturns $1.2 Billion Verdict Against Gilead Sciences, Invalidates Bristol Myers CAR-T Patent